Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Research presented at the 2025 European Association for the Study of Diabetes meeting confirmed that semaglutide users report significantly fewer obsessive thoughts about food
.png)
QL Biopharm Completes Dosing of First Patient in HORIZON-1, a Phase 3 Trial for Weight Loss with Zovaglutide, a Once-Monthly GLP-1 RA Peptide BEIJING, China, January 19, 2026 On January 16, 2026, Beijing QL Biopharmaceutical Co, Ltd (QL Biopharm) dosed the first patient in its Phase 3 clinical trial, HORIZON-1, which will evaluate QL Biopharms ultra-long-acting GLP-1 receptor agonist (GLP-1 RA), zovaglutide (ZT002)
Schedule a consultation with DripGym today to explore our peptide-based programs
Next, we only studied relatively young patients (35 years old), and we therefore cannot extrapolate our findings to a broader patient range
Adlumiz subsequently approved by the Japan PMDA on January 22, 2021 for cancer cachexia in NSCLC, gastric, pancreatic, and colorectal cancers
Retrieved from Murphy, E
US$ 29.75
US$ 29.44
US$ 26.50
US$ 21.86
US$ 22.48
US$ 20.78
US$ 22.18
US$ 23.79
US$ 21.74
